Загрузка...
Identification and Characterization of Two Novel Oncogenic mTOR Mutations
Mammalian target of rapamycin (mTOR) signaling is often aberrantly activated, particularly when genetically activated, in human cancers. mTOR inhibitors targeting the activated mTOR signaling are highly promising anti-cancer drugs. Knowing the activating genetic change in mTOR can help guide the use...
Сохранить в:
| Опубликовано в: : | Oncogene |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597304/ https://ncbi.nlm.nih.gov/pubmed/30918329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-0787-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|